id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8484 R27833 |
Yoshihara (Controls exposed to MMI), 2021 | Omphalocele | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.21 [0.01;4.48] C excluded (control group) |
2/541 0/23 | 2 | 541 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8481 R27767 |
Yoshihara (Controls unexposed, sick), 2021 | Omphalocele | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 0.58 [0.10;3.51] C | 2/541 3/475 | 5 | 541 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3355 R6066 |
Yoshihara (control exposed to MMI), 2012 | Omphalocele | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.07 [0.00;1.20] C excluded (control group) |
0/1,399 6/1,231 | 6 | 1,399 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3354 R6023 |
Yoshihara (control unexposed, sick), 2012 | Omphalocele | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 1.36 [0.03;68.71] C | 0/1,399 0/1,906 | 0 | 1,399 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3380 R6258 |
Clementi, 2010 | Omphalocele | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No | 1.23 [0.08;20.04] C | 0/47 154/18,084 | 154 | 47 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 0.79 [0.19;3.22] | 159 | 1,987 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick; 2: control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3355, 8484